INTERNATIONAL PATENT: ABBVIE INC. FILES APPLICATION FOR "CLOSTRIDIUM BOTULINUM NEUROTOXIN SEROTYPE A COMPOSITIONS AND IMPROVED FILTRATION PROCESSES"

GENEVA, June 4 -- ABBVIE INC. (1 North Waukegan RoadNorth Chicago, IL 60064) filed a patent application (PCT/US2024/056505) for "CLOSTRIDIUM BOTULINUM NEUROTOXIN SEROTYPE A COMPOSITIONS AND IMPROVED FILTRATION PROCESSES" on Nov 19, 2024. With publication no. WO/2025/111258, the details related to the patent application was published on May 30, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): SHALAEV, Evgenyi (33776 Bridgehampton DriveDana Point, CA 92629), ABIAD, Maurice (5918 Bixby Village Drive, #111Long Beach, CA 90803)

Abstract: Provided herein are compositions comprising Clostridium b...